1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Veterinary Vaccines

1.2 Classification of Veterinary Vaccines by Type

1.2.1 Overview: Global Veterinary Vaccines Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Veterinary Vaccines Revenue Market Share by Type in 2021

1.2.3 Inactivated Vaccines

1.2.4 Live Attenuated Vaccines

1.2.5 Conjugate Vaccines

1.2.6 Toxoid Vaccines

1.2.7 Recombinant Vaccines

1.2.8 DNA Vaccines

1.2.9 Others

1.3 Global Veterinary Vaccines Market by Application

1.3.1 Overview: Global Veterinary Vaccines Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Veterinary Clinic

1.3.3 Veterinary Hospital

1.3.4 Veterinary Research Institute

1.3.5 Retail Pharmacy

1.3.6 Others

1.4 Global Veterinary Vaccines Market Size & Forecast

1.5 Global Veterinary Vaccines Market Size and Forecast by Region

1.5.1 Global Veterinary Vaccines Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Veterinary Vaccines Market Size by Region, (2017-2022)

1.5.3 North America Veterinary Vaccines Market Size and Prospect (2017-2028)

1.5.4 Europe Veterinary Vaccines Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Veterinary Vaccines Market Size and Prospect (2017-2028)

1.5.6 South America Veterinary Vaccines Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Veterinary Vaccines Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Veterinary Vaccines Market Drivers

1.6.2 Veterinary Vaccines Market Restraints

1.6.3 Veterinary Vaccines Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Elanco

2.1.1 Elanco Details

2.1.2 Elanco Major Business

2.1.3 Elanco Veterinary Vaccines Product and Solutions

2.1.4 Elanco Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Elanco Recent Developments and Future Plans

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck Veterinary Vaccines Product and Solutions

2.2.4 Merck Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Merck Recent Developments and Future Plans

2.3 Merial

2.3.1 Merial Details

2.3.2 Merial Major Business

2.3.3 Merial Veterinary Vaccines Product and Solutions

2.3.4 Merial Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Merial Recent Developments and Future Plans

2.4 Zoetis

2.4.1 Zoetis Details

2.4.2 Zoetis Major Business

2.4.3 Zoetis Veterinary Vaccines Product and Solutions

2.4.4 Zoetis Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Zoetis Recent Developments and Future Plans

2.5 Advaxis

2.5.1 Advaxis Details

2.5.2 Advaxis Major Business

2.5.3 Advaxis Veterinary Vaccines Product and Solutions

2.5.4 Advaxis Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Advaxis Recent Developments and Future Plans

2.6 AmpliPhi Biosciences

2.6.1 AmpliPhi Biosciences Details

2.6.2 AmpliPhi Biosciences Major Business

2.6.3 AmpliPhi Biosciences Veterinary Vaccines Product and Solutions

2.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 AmpliPhi Biosciences Recent Developments and Future Plans

2.7 Aratana Therapeutics

2.7.1 Aratana Therapeutics Details

2.7.2 Aratana Therapeutics Major Business

2.7.3 Aratana Therapeutics Veterinary Vaccines Product and Solutions

2.7.4 Aratana Therapeutics Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Aratana Therapeutics Recent Developments and Future Plans

2.8 ARKO Labs

2.8.1 ARKO Labs Details

2.8.2 ARKO Labs Major Business

2.8.3 ARKO Labs Veterinary Vaccines Product and Solutions

2.8.4 ARKO Labs Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 ARKO Labs Recent Developments and Future Plans

2.9 Bayer

2.9.1 Bayer Details

2.9.2 Bayer Major Business

2.9.3 Bayer Veterinary Vaccines Product and Solutions

2.9.4 Bayer Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bayer Recent Developments and Future Plans

2.10 CanFel Therapeutics

2.10.1 CanFel Therapeutics Details

2.10.2 CanFel Therapeutics Major Business

2.10.3 CanFel Therapeutics Veterinary Vaccines Product and Solutions

2.10.4 CanFel Therapeutics Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 CanFel Therapeutics Recent Developments and Future Plans

2.11 Ceva Animal Health

2.11.1 Ceva Animal Health Details

2.11.2 Ceva Animal Health Major Business

2.11.3 Ceva Animal Health Veterinary Vaccines Product and Solutions

2.11.4 Ceva Animal Health Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Ceva Animal Health Recent Developments and Future Plans

2.12 Colorado Serum

2.12.1 Colorado Serum Details

2.12.2 Colorado Serum Major Business

2.12.3 Colorado Serum Veterinary Vaccines Product and Solutions

2.12.4 Colorado Serum Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Colorado Serum Recent Developments and Future Plans

2.13 Epitopix

2.13.1 Epitopix Details

2.13.2 Epitopix Major Business

2.13.3 Epitopix Veterinary Vaccines Product and Solutions

2.13.4 Epitopix Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Epitopix Recent Developments and Future Plans

2.14 Genus

2.14.1 Genus Details

2.14.2 Genus Major Business

2.14.3 Genus Veterinary Vaccines Product and Solutions

2.14.4 Genus Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Genus Recent Developments and Future Plans

2.15 Hygieia Biological Laboratories

2.15.1 Hygieia Biological Laboratories Details

2.15.2 Hygieia Biological Laboratories Major Business

2.15.3 Hygieia Biological Laboratories Veterinary Vaccines Product and Solutions

2.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Hygieia Biological Laboratories Recent Developments and Future Plans

2.16 ImmuCell

2.16.1 ImmuCell Details

2.16.2 ImmuCell Major Business

2.16.3 ImmuCell Veterinary Vaccines Product and Solutions

2.16.4 ImmuCell Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 ImmuCell Recent Developments and Future Plans

2.17 Nexvet

2.17.1 Nexvet Details

2.17.2 Nexvet Major Business

2.17.3 Nexvet Veterinary Vaccines Product and Solutions

2.17.4 Nexvet Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Nexvet Recent Developments and Future Plans

2.18 Nuovo Biologics

2.18.1 Nuovo Biologics Details

2.18.2 Nuovo Biologics Major Business

2.18.3 Nuovo Biologics Veterinary Vaccines Product and Solutions

2.18.4 Nuovo Biologics Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Nuovo Biologics Recent Developments and Future Plans

2.19 UBI

2.19.1 UBI Details

2.19.2 UBI Major Business

2.19.3 UBI Veterinary Vaccines Product and Solutions

2.19.4 UBI Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 UBI Recent Developments and Future Plans

2.20 Valneva

2.20.1 Valneva Details

2.20.2 Valneva Major Business

2.20.3 Valneva Veterinary Vaccines Product and Solutions

2.20.4 Valneva Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 Valneva Recent Developments and Future Plans

2.21 Vetoquinol

2.21.1 Vetoquinol Details

2.21.2 Vetoquinol Major Business

2.21.3 Vetoquinol Veterinary Vaccines Product and Solutions

2.21.4 Vetoquinol Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Vetoquinol Recent Developments and Future Plans

2.22 Virbac

2.22.1 Virbac Details

2.22.2 Virbac Major Business

2.22.3 Virbac Veterinary Vaccines Product and Solutions

2.22.4 Virbac Veterinary Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Virbac Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Veterinary Vaccines Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Veterinary Vaccines Players Market Share in 2021

3.2.2 Top 10 Veterinary Vaccines Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Veterinary Vaccines Players Head Office, Products and Services Provided

3.4 Veterinary Vaccines Mergers & Acquisitions

3.5 Veterinary Vaccines New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Veterinary Vaccines Revenue and Market Share by Type (2017-2022)

4.2 Global Veterinary Vaccines Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Veterinary Vaccines Revenue Market Share by Application (2017-2022)

5.2 Global Veterinary Vaccines Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Veterinary Vaccines Revenue by Type (2017-2028)

6.2 North America Veterinary Vaccines Revenue by Application (2017-2028)

6.3 North America Veterinary Vaccines Market Size by Country

6.3.1 North America Veterinary Vaccines Revenue by Country (2017-2028)

6.3.2 United States Veterinary Vaccines Market Size and Forecast (2017-2028)

6.3.3 Canada Veterinary Vaccines Market Size and Forecast (2017-2028)

6.3.4 Mexico Veterinary Vaccines Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Veterinary Vaccines Revenue by Type (2017-2028)

7.2 Europe Veterinary Vaccines Revenue by Application (2017-2028)

7.3 Europe Veterinary Vaccines Market Size by Country

7.3.1 Europe Veterinary Vaccines Revenue by Country (2017-2028)

7.3.2 Germany Veterinary Vaccines Market Size and Forecast (2017-2028)

7.3.3 France Veterinary Vaccines Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Veterinary Vaccines Market Size and Forecast (2017-2028)

7.3.5 Russia Veterinary Vaccines Market Size and Forecast (2017-2028)

7.3.6 Italy Veterinary Vaccines Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Veterinary Vaccines Revenue by Type (2017-2028)

8.2 Asia-Pacific Veterinary Vaccines Revenue by Application (2017-2028)

8.3 Asia-Pacific Veterinary Vaccines Market Size by Region

8.3.1 Asia-Pacific Veterinary Vaccines Revenue by Region (2017-2028)

8.3.2 China Veterinary Vaccines Market Size and Forecast (2017-2028)

8.3.3 Japan Veterinary Vaccines Market Size and Forecast (2017-2028)

8.3.4 South Korea Veterinary Vaccines Market Size and Forecast (2017-2028)

8.3.5 India Veterinary Vaccines Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Veterinary Vaccines Market Size and Forecast (2017-2028)

8.3.7 Australia Veterinary Vaccines Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Veterinary Vaccines Revenue by Type (2017-2028)

9.2 South America Veterinary Vaccines Revenue by Application (2017-2028)

9.3 South America Veterinary Vaccines Market Size by Country

9.3.1 South America Veterinary Vaccines Revenue by Country (2017-2028)

9.3.2 Brazil Veterinary Vaccines Market Size and Forecast (2017-2028)

9.3.3 Argentina Veterinary Vaccines Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Veterinary Vaccines Revenue by Type (2017-2028)

10.2 Middle East & Africa Veterinary Vaccines Revenue by Application (2017-2028)

10.3 Middle East & Africa Veterinary Vaccines Market Size by Country

10.3.1 Middle East & Africa Veterinary Vaccines Revenue by Country (2017-2028)

10.3.2 Turkey Veterinary Vaccines Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Veterinary Vaccines Market Size and Forecast (2017-2028)

10.3.4 UAE Veterinary Vaccines Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Veterinary Vaccines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Veterinary Vaccines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Veterinary Vaccines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Veterinary Vaccines Revenue (USD Million) by Region (2017-2022)

Table 5. Global Veterinary Vaccines Revenue Market Share by Region (2023-2028)

Table 6. Elanco Corporate Information, Head Office, and Major Competitors

Table 7. Elanco Major Business

Table 8. Elanco Veterinary Vaccines Product and Solutions

Table 9. Elanco Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Merck Corporate Information, Head Office, and Major Competitors

Table 11. Merck Major Business

Table 12. Merck Veterinary Vaccines Product and Solutions

Table 13. Merck Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Merial Corporate Information, Head Office, and Major Competitors

Table 15. Merial Major Business

Table 16. Merial Veterinary Vaccines Product and Solutions

Table 17. Merial Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Zoetis Corporate Information, Head Office, and Major Competitors

Table 19. Zoetis Major Business

Table 20. Zoetis Veterinary Vaccines Product and Solutions

Table 21. Zoetis Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Advaxis Corporate Information, Head Office, and Major Competitors

Table 23. Advaxis Major Business

Table 24. Advaxis Veterinary Vaccines Product and Solutions

Table 25. Advaxis Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. AmpliPhi Biosciences Corporate Information, Head Office, and Major Competitors

Table 27. AmpliPhi Biosciences Major Business

Table 28. AmpliPhi Biosciences Veterinary Vaccines Product and Solutions

Table 29. AmpliPhi Biosciences Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Aratana Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Aratana Therapeutics Major Business

Table 32. Aratana Therapeutics Veterinary Vaccines Product and Solutions

Table 33. Aratana Therapeutics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. ARKO Labs Corporate Information, Head Office, and Major Competitors

Table 35. ARKO Labs Major Business

Table 36. ARKO Labs Veterinary Vaccines Product and Solutions

Table 37. ARKO Labs Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bayer Corporate Information, Head Office, and Major Competitors

Table 39. Bayer Major Business

Table 40. Bayer Veterinary Vaccines Product and Solutions

Table 41. Bayer Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. CanFel Therapeutics Corporate Information, Head Office, and Major Competitors

Table 43. CanFel Therapeutics Major Business

Table 44. CanFel Therapeutics Veterinary Vaccines Product and Solutions

Table 45. CanFel Therapeutics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Ceva Animal Health Corporate Information, Head Office, and Major Competitors

Table 47. Ceva Animal Health Major Business

Table 48. Ceva Animal Health Veterinary Vaccines Product and Solutions

Table 49. Ceva Animal Health Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Colorado Serum Corporate Information, Head Office, and Major Competitors

Table 51. Colorado Serum Major Business

Table 52. Colorado Serum Veterinary Vaccines Product and Solutions

Table 53. Colorado Serum Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Epitopix Corporate Information, Head Office, and Major Competitors

Table 55. Epitopix Major Business

Table 56. Epitopix Veterinary Vaccines Product and Solutions

Table 57. Epitopix Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Genus Corporate Information, Head Office, and Major Competitors

Table 59. Genus Major Business

Table 60. Genus Veterinary Vaccines Product and Solutions

Table 61. Genus Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Hygieia Biological Laboratories Corporate Information, Head Office, and Major Competitors

Table 63. Hygieia Biological Laboratories Major Business

Table 64. Hygieia Biological Laboratories Veterinary Vaccines Product and Solutions

Table 65. Hygieia Biological Laboratories Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. ImmuCell Corporate Information, Head Office, and Major Competitors

Table 67. ImmuCell Major Business

Table 68. ImmuCell Veterinary Vaccines Product and Solutions

Table 69. ImmuCell Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Nexvet Corporate Information, Head Office, and Major Competitors

Table 71. Nexvet Major Business

Table 72. Nexvet Veterinary Vaccines Product and Solutions

Table 73. Nexvet Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Nuovo Biologics Corporate Information, Head Office, and Major Competitors

Table 75. Nuovo Biologics Major Business

Table 76. Nuovo Biologics Veterinary Vaccines Product and Solutions

Table 77. Nuovo Biologics Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. UBI Corporate Information, Head Office, and Major Competitors

Table 79. UBI Major Business

Table 80. UBI Veterinary Vaccines Product and Solutions

Table 81. UBI Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Valneva Corporate Information, Head Office, and Major Competitors

Table 83. Valneva Major Business

Table 84. Valneva Veterinary Vaccines Product and Solutions

Table 85. Valneva Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Vetoquinol Corporate Information, Head Office, and Major Competitors

Table 87. Vetoquinol Major Business

Table 88. Vetoquinol Veterinary Vaccines Product and Solutions

Table 89. Vetoquinol Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Virbac Corporate Information, Head Office, and Major Competitors

Table 91. Virbac Major Business

Table 92. Virbac Veterinary Vaccines Product and Solutions

Table 93. Virbac Veterinary Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Global Veterinary Vaccines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 95. Global Veterinary Vaccines Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 96. Breakdown of Veterinary Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. Veterinary Vaccines Players Head Office, Products and Services Provided

Table 98. Veterinary Vaccines Mergers & Acquisitions in the Past Five Years

Table 99. Veterinary Vaccines New Entrants and Expansion Plans

Table 100. Global Veterinary Vaccines Revenue (USD Million) by Type (2017-2022)

Table 101. Global Veterinary Vaccines Revenue Share by Type (2017-2022)

Table 102. Global Veterinary Vaccines Revenue Forecast by Type (2023-2028)

Table 103. Global Veterinary Vaccines Revenue by Application (2017-2022)

Table 104. Global Veterinary Vaccines Revenue Forecast by Application (2023-2028)

Table 105. North America Veterinary Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 106. North America Veterinary Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 107. North America Veterinary Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 108. North America Veterinary Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 109. North America Veterinary Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 110. North America Veterinary Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 111. Europe Veterinary Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 112. Europe Veterinary Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 113. Europe Veterinary Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 114. Europe Veterinary Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 115. Europe Veterinary Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 116. Europe Veterinary Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 117. Asia-Pacific Veterinary Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 118. Asia-Pacific Veterinary Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 119. Asia-Pacific Veterinary Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 120. Asia-Pacific Veterinary Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 121. Asia-Pacific Veterinary Vaccines Revenue by Region (2017-2022) & (USD Million)

Table 122. Asia-Pacific Veterinary Vaccines Revenue by Region (2023-2028) & (USD Million)

Table 123. South America Veterinary Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 124. South America Veterinary Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 125. South America Veterinary Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 126. South America Veterinary Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 127. South America Veterinary Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 128. South America Veterinary Vaccines Revenue by Country (2023-2028) & (USD Million)

Table 129. Middle East & Africa Veterinary Vaccines Revenue by Type (2017-2022) & (USD Million)

Table 130. Middle East & Africa Veterinary Vaccines Revenue by Type (2023-2028) & (USD Million)

Table 131. Middle East & Africa Veterinary Vaccines Revenue by Application (2017-2022) & (USD Million)

Table 132. Middle East & Africa Veterinary Vaccines Revenue by Application (2023-2028) & (USD Million)

Table 133. Middle East & Africa Veterinary Vaccines Revenue by Country (2017-2022) & (USD Million)

Table 134. Middle East & Africa Veterinary Vaccines Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Veterinary Vaccines Picture

Figure 2. Global Veterinary Vaccines Revenue Market Share by Type in 2021

Figure 3. Inactivated Vaccines

Figure 4. Live Attenuated Vaccines

Figure 5. Conjugate Vaccines

Figure 6. Toxoid Vaccines

Figure 7. Recombinant Vaccines

Figure 8. DNA Vaccines

Figure 9. Others

Figure 10. Veterinary Vaccines Revenue Market Share by Application in 2021

Figure 11. Veterinary Clinic Picture

Figure 12. Veterinary Hospital Picture

Figure 13. Veterinary Research Institute Picture

Figure 14. Retail Pharmacy Picture

Figure 15. Others Picture

Figure 16. Global Veterinary Vaccines Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 17. Global Veterinary Vaccines Revenue and Forecast (2017-2028) & (USD Million)

Figure 18. Global Veterinary Vaccines Revenue Market Share by Region (2017-2028)

Figure 19. Global Veterinary Vaccines Revenue Market Share by Region in 2021

Figure 20. North America Veterinary Vaccines Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Europe Veterinary Vaccines Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Asia-Pacific Veterinary Vaccines Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. South America Veterinary Vaccines Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Middle East and Africa Veterinary Vaccines Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. Veterinary Vaccines Market Drivers

Figure 26. Veterinary Vaccines Market Restraints

Figure 27. Veterinary Vaccines Market Trends

Figure 28. Elanco Recent Developments and Future Plans

Figure 29. Merck Recent Developments and Future Plans

Figure 30. Merial Recent Developments and Future Plans

Figure 31. Zoetis Recent Developments and Future Plans

Figure 32. Advaxis Recent Developments and Future Plans

Figure 33. AmpliPhi Biosciences Recent Developments and Future Plans

Figure 34. Aratana Therapeutics Recent Developments and Future Plans

Figure 35. ARKO Labs Recent Developments and Future Plans

Figure 36. Bayer Recent Developments and Future Plans

Figure 37. CanFel Therapeutics Recent Developments and Future Plans

Figure 38. Ceva Animal Health Recent Developments and Future Plans

Figure 39. Colorado Serum Recent Developments and Future Plans

Figure 40. Epitopix Recent Developments and Future Plans

Figure 41. Genus Recent Developments and Future Plans

Figure 42. Hygieia Biological Laboratories Recent Developments and Future Plans

Figure 43. ImmuCell Recent Developments and Future Plans

Figure 44. Nexvet Recent Developments and Future Plans

Figure 45. Nuovo Biologics Recent Developments and Future Plans

Figure 46. UBI Recent Developments and Future Plans

Figure 47. Valneva Recent Developments and Future Plans

Figure 48. Vetoquinol Recent Developments and Future Plans

Figure 49. Virbac Recent Developments and Future Plans

Figure 50. Global Veterinary Vaccines Revenue Share by Players in 2021

Figure 51. Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 52. Global Top 3 Players Veterinary Vaccines Revenue Market Share in 2021

Figure 53. Global Top 10 Players Veterinary Vaccines Revenue Market Share in 2021

Figure 54. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 55. Global Veterinary Vaccines Revenue Share by Type in 2021

Figure 56. Global Veterinary Vaccines Market Share Forecast by Type (2023-2028)

Figure 57. Global Veterinary Vaccines Revenue Share by Application in 2021

Figure 58. Global Veterinary Vaccines Market Share Forecast by Application (2023-2028)

Figure 59. North America Veterinary Vaccines Sales Market Share by Type (2017-2028)

Figure 60. North America Veterinary Vaccines Sales Market Share by Application (2017-2028)

Figure 61. North America Veterinary Vaccines Revenue Market Share by Country (2017-2028)

Figure 62. United States Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Canada Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Mexico Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Europe Veterinary Vaccines Sales Market Share by Type (2017-2028)

Figure 66. Europe Veterinary Vaccines Sales Market Share by Application (2017-2028)

Figure 67. Europe Veterinary Vaccines Revenue Market Share by Country (2017-2028)

Figure 68. Germany Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. France Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. United Kingdom Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Russia Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Italy Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Asia-Pacific Veterinary Vaccines Sales Market Share by Type (2017-2028)

Figure 74. Asia-Pacific Veterinary Vaccines Sales Market Share by Application (2017-2028)

Figure 75. Asia-Pacific Veterinary Vaccines Revenue Market Share by Region (2017-2028)

Figure 76. China Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Japan Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South Korea Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. India Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Southeast Asia Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Australia Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. South America Veterinary Vaccines Sales Market Share by Type (2017-2028)

Figure 83. South America Veterinary Vaccines Sales Market Share by Application (2017-2028)

Figure 84. South America Veterinary Vaccines Revenue Market Share by Country (2017-2028)

Figure 85. Brazil Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 86. Argentina Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Middle East and Africa Veterinary Vaccines Sales Market Share by Type (2017-2028)

Figure 88. Middle East and Africa Veterinary Vaccines Sales Market Share by Application (2017-2028)

Figure 89. Middle East and Africa Veterinary Vaccines Revenue Market Share by Country (2017-2028)

Figure 90. Turkey Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 91. Saudi Arabia Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 92. UAE Veterinary Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 93. Methodology

Figure 94. Research Process and Data Source